Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Sleep Medicine ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Central sleep apnea.Compr Physiol. 2013; 3: 141-163
Javaheri S. Heart failure. In: Kryger MH, Roth T, Dement WC, editors. Principles and practices of sleep medicine. 6th edition. Philadelphia: WB Saunders, in press.
- Cheyne-Stokes respiration presenting as sleep apnea syndrome. Clinical and polysomnographic features.Am Rev Respir Dis. 1990; 141: 871-879
- Acetazolamide attenuates Hunter-Cheyne-Stokes breathing yet paradoxically augments the hypercapnic ventilatory response in patients with heart failure.Ann Am Thorac Soc. 2014; 11: 80-86
- Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure.J Cardiol. 2012; 18: 534-540
- Central sleep apnea, right ventricular dysfunction and low diastolic blood pressure are predictors of mortality in systolic heart failure.J Am Coll Cardiol. 2007; 49: 2028-2034
- Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure.Am J Respir Crit Care Med. 2011; 183: 539-546
- Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction.Eur J Heart Fail. 2009; 11: 602-608
- High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function.J Card Fail. 2011; 17: 420-425
- In-hospital testing for sleep-disordered breathing in hospitalized patients with decompensated heart failure: report of prevalence and patient characteristics.J Card Fail. 2009; 15: 739-746
- Heart failure.in: The encyclopedia of sleep. vol. 3. Academic Press, Waltham (MA)2013: 374-386
- Positive airway pressure therapy with adaptive servo-ventilation (part II: clinical applications).Chest. 2014; 146: 855-868
- Prevalence of obstructive sleep apnea and periodic limb movement in 45 subjects with heart transplantation.Eur Heart J. 2004; 25: 260-266
- Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure.Eur Heart J. 2012; 33: 889-894
- Continuous positive airway pressure for central sleep apnea and heart failure.N Engl J Med. 2006; 353: 2025-2033
- CPAP should not be used for central sleep apnea in congestive heart failure patients.J Clin Sleep Med. 2006; 2: 399-402
- Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure.Circulation. 2000; 101: 392-397
- Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure. A post-hoc analysis of the Canadian Continuous Positive Airway Pressure for patients with central sleep apnea and heart failure trial (CANPAP).Circulation. 2007; 115: 3173-3180
- Shift in sleep apnoea type in heart failure patients in the CANPAP trial.Eur Respir J. 2010; 35: 592-597
- Positive airway pressure therapy with adaptive servoventilation (part 1: operational algorithms).Chest. 2014; 146: 514-523
- Adaptive servoventilation for the treatment of central sleep apnea in congestive heart failure: what have we learned?.Curr Opin Pulm Med. 2014; 20: 550-557
- Nocturnal noninvasive ventilation in heart failure.in: Basner R.C. Parthasarathy S. Nocturnal non-invasive ventilation: theory, evidence, and practice. Springer Science, New York2015: 73-81
- Adaptive servo-ventilation in central sleep apnea.Sleep Med Clin. 2014; 9: 69-85
- Adaptive servo-ventilation for central sleep apnea in systolic heart failure.N Engl J Med. 2015; 373: 1095-1105
- Adaptive servoventilation in patients with central or complex sleep apnea related to chronic opioid use and congestive heart failure.J Clin Sleep Med. 2012; 8: 569-576
- Transvenous phrenic nerve stimulation in patients with Cheyne-Stokes respiration and congestive heart failure—a safety and proof-of-concept study.Chest. 2012; 142: 927-934
- Safety and feasibility of chronic transvenous phrenic nerve stimulation for the treatment of central sleep apnea in heart failure patients.Clin Respir J. 2015; https://doi.org/10.1111/crj. 12320
- Phrenic nerve stimulation for the treatment of central sleep apnea.JACC Heart Fail. 2015; 5: 360-369
- Design of the remedē® system pivotal trial: a prospective, randomized study in the use of respiratory rhythm management to treat central sleep apnea.J Card Fail. 2015; 21: 892-902
- Trends in medical use abuse of opioid analgesics.JAMA. 2000; 283: 1710-1714
- ARCOS. Automation of reports and consolidated orders system Retail drug summary. US Department of Justice; DEA, 2005
- Monitoring the future (MTF) survey, US. Services DoHaH, 2005
- Unintentional drug poisoning in the United States. National Center for Injury Prevention and Control CfDCaP, 2010
- Increase in poisoning deaths caused by non-illicit drugs—Utah 1991-2003.MMWR Morb Mortal Wkly Rep. 2005; 54: 3-6
- Adaptive pressure support servoventilation: a novel treatment for sleep apnea associated with use of opioids.J Clin Sleep Med. 2008; 4: 305-310
- Adaptive servo-ventilation for treatment of opioids-associated central sleep apnea.J Clin Sleep Med. 2014; 10: 637-643
- Sleep-disordered breathing and chronic opioid therapy.Pain Med. 2008; 9: 425-432
- Sleep-disordered breathing in stable methadone programme patients: a pilot study.Addiction. 2001; 96: 395-403
- Sleep-disordered breathing associated with long-term opioid therapy.Chest. 2003; 123: 632-639
- Adaptive servoventilation (ASV) in patients with sleep disordered breathing associated with chronic opioid medications for non-malignant pain.J Clin Sleep Med. 2008; 4: 311-319
- Opioid induced central sleep apnea.in: Fabiani M. Proceedings of the X World Congress on sleep apnea, section: respiratory disorders and snoring. Edizioni Minerva Medica, Turin (Italy)2012: 133-137
- Chronic opioid use: effects on respiration and sleep.in: Tvildiani D. Gegechkori K. Opioids pharmacology, clinical uses and adverse effects. Nova Science Publishers, Inc, New York2012: 1-13
- Opioids, sedatives, and sleep hypoventilation.Sleep Med Clin. 2014; 9: 391-398
- The prevalence and natural history of complex sleep apnea.J Clin Sleep Med. 2009; 5: 205-211
- Efficacy of adaptive servoventilation in treatment of complex and central sleep apnea syndromes.Chest. 2007; 132: 1839-1846
- A novel adaptive servoventilation (ASVAuto) for the treatment of central sleep apnea associated with chronic use of opioids.J Clin Sleep Med. 2014; 10: 855-861
- Positive airway pressure therapy in patients with opioid-related central sleep apnea.Sleep Breath. 2014; 18: 367-373
- Obstructive sleep apnea and chronic opioid use.Lung. 2010; 188: 459-468
- Ampakines alleviate respiratory depression in rats.Am J Respir Crit Care Med. 2006; 174: 1384-1391
- Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats.Anesthesiology. 2009; 110: 1364-1370
- Respiratory depression in rats induced by alcohol and barbiturate and alleviation by ampakine CX717.J Appl Physiol (1985). 2012; 113: 1004-1011
- Co-administration of the ampakine CX717 with propofol reduces respiratory depression and fatal apneas.Anesthesiology. 2013; 118: 1437-1445
- Ampakines enhance weak endogenous respiratory drive and apnea in perinatal rats.Am J Respir Crit Care Med. 2015; 191: 704-710
- Stimulation of respiratory motor output and ventilation in a murine model of Pompe disease by ampakines.Am J Respir Cell Mol Biol. 2015; 53: 326-335
- Selective antagonism of opioid-induced respiratory depression by an AMPAKINE molecule in humans without loss of opioid analgesia.Clin Pharmacol Ther. 2010; 87: 204-211
- The role of excitatory amino acids in the generation and transmission of respiratory drive in the neonatal rat.J Physiol. 1991; 1001: 727-749
- AMPA receptor activation and phosphatase inhibition affect neonatal rat respiratory rhythm generation.J Physiol. 1998; 509: 255-266
- Generation and transmission of respiratory oscillations in medullary slices: role of excitatory amino acids.J Neurophysiol. 1993; 70: 1497-1515
- Inspiratory bursts in the preBötzinger complex depend on a calcium-activated non-specific cation current linked to glutamate receptors in neonatal mice.J Physiol. 2007; 582: 113-125
- Excitatory amino acid-mediated transmission of inspiratory drive to phrenic motoneurons.J Neurophysiol. 1990; 64: 423-436
- NMDA as well as non-NMDA receptors mediate the neurotransmission of inspiratory drive to phrenic motoneurons in the adult rat.Brain Res. 1996; 715: 104-112
- Glutamate-based therapeutic approaches: ampakines.Curr Opin Pharmacol. 2006; 6: 82-88
- Ampakines and the threefold path to cognitive enhancement.Trends Neurosci. 2006; 29: 554-562
- Modulation of AMPA receptor kinetics differentially influences synaptic plasticity in the hippocampus.Neuroscience. 2004; 123: 1011-1024
- Generation of respiratory and locomotor patterns by an in vitro brainstem-spinal cord fetal rat preparation.J Neurophysiol. 1992; 67: 996-999
- Neural mechanisms generating respiratory pattern in mammalian brainstem-spinal cord in vitro. I. Spatiotemporal patterns of motor and medullary neuron activity.J Neurophysiol. 1990; 64: 1149-1169
- PreBötzinger complex: a brainstem region that may generate respiratory rhythm in mammals.Science. 1991; 1001: 726-729
- Opiate-induced suppression of rat hypoglossal motoneuron activity and its reversal by ampakine therapy.PLoS One. 2010; 5: e8766
Article info
Identification
Copyright
© 2016 Elsevier Inc. All rights reserved.
